Axicabtagene Ciloleucel Outperforms Conventional First-Line Therapy
In a groundbreaking comparative study published in BMC Cancer, researchers have provided compelling evidence demonstrating the superiority of axicabtagene ciloleucel ...
In a groundbreaking comparative study published in BMC Cancer, researchers have provided compelling evidence demonstrating the superiority of axicabtagene ciloleucel ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine